From my colleague Andrew Joseph: After a bumpy road, Eisai and Biogen’s Alzheimer’s therapy Leqembi has won approval in ...

The company that made its name by providing ... The restructuring comes after a turbulent period at 23andMe, with a steep decline in its share price – down more than 70% this year – negative ...

Three congressmen on the House Committee on Energy and Commerce sent a letter to the genetic testing company 23andMe on ...

A group of House lawmakers launched a probe Thursday into 23andMe’s handling of customers’ sensitive data following the ...

Me has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the largest ...

23andMe exploded into the mainstream with its at-home DNA testing kits that gave customers insight into their family ...

Late last month, genetic testing giant 23andMe filed for bankruptcy. The San Francisco-based company — cofounded in 2006 by former healthcare investor Anne Wojcicki — rose to fame for offering ...

A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the ...

On March 23, 2025, 23andMe, along with its affiliates, filed for voluntary Chapter 11 bankruptcy. The company’s decision to file for bankruptcy follows in the wake of a 2023 data breach ...

The investigation comes after the genetic testing company filed for bankruptcy earlier this year, raising questions about the ...